Coya Therapeutics (COYA) Asset Utilization Ratio (2023 - 2026)

Coya Therapeutics has disclosed Asset Utilization Ratio across 4 years of filings, most recently posting 0.16 for Q2 2026.

• In Q2 2026, Asset Utilization Ratio rose 1252.97% year-over-year to 0.16; the TTM figure through Jun 2026 stood at 0.16 (up 1252.97% YoY), while the FY2025 annual figure was 0.17, up 102.97% from the prior year.
• Asset Utilization Ratio came in at 0.16 for Q2 2026 at Coya Therapeutics, up from 0.15 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.25 in Q3 2024 to a low of 0.01 in Q2 2025.
• Average Asset Utilization Ratio over 4 years is 0.15, with a median of 0.16 recorded in 2024.
• Year-over-year, Asset Utilization Ratio tumbled 95.23% in 2025 and surged 1252.97% in 2026.
• Over 4 years, Asset Utilization Ratio stood at 0.23 in 2023, then plunged by 60.61% to 0.09 in 2024, then soared by 117.86% to 0.19 in 2025, then fell by 17.73% to 0.16 in 2026.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.16 in Q2 2026, 0.15 in Q1 2026, and 0.19 in Q4 2025.